Maria Maccecchini's most recent trade in Lantern Pharma Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lantern Pharma Inc | Maria Maccecchini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 20 Nov 2023 | 40,970 | 1,098,459 (16%) | 0% | 6.1 | 249,917 | Common Stock |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 252,000 | 252,000 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 108,800 | 108,800 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2023 | 10,000 | 1,088,459 (16%) | 0% | 0 | Common Stock | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2023 | 10,000 | 1,078,459 (16%) | 0% | 0 | Common Stock | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2023 | 10,000 | 1,068,459 (16%) | 0% | 0 | Common Stock | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Apr 2023 | 3,000 | 1,057,489 (16%) | 0% | 0 | Common Stock | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 12.61 per share. | 07 Apr 2023 | 20,000 | 1,060,489 (16%) | 0% | 12.6 | 252,200 | Common Stock |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 52,755 | 0 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 06 Feb 2023 | 52,755 | 1,040,489 (15%) | 0% | 0.1 | 7,386 | Common Stock |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 21,312 | 21,312 | - | - | Stock Option (right to buy) | |
Lantern Pharma Inc | Maria Maccecchini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 3,200 | 3,200 | - | - | Stock Option (Right to Buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 14 Jan 2022 | 32,959 | 987,734 (15%) | 0% | 0.1 | 4,614 | Common Stock |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 32,959 | 52,755 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 83,400 | 83,400 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 19,894 | 19,894 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 145,305 | 145,305 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 112,995 | 112,995 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, PRESIDENT AND CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 27.61 per share. | 11 Oct 2021 | 18,000 | 976,775 (14%) | 0% | 27.6 | 496,980 | Common Stock |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 41,700 | 41,700 | - | - | Stock Option (right to buy) | |
Annovis Bio Inc | Maria Maccecchini | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2020 | 300,000 | 300,000 | - | - | Stock Option (right to buy) |